Eligibility Criteria: Too Big, Too Small or Just Right?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kim E, Bruinooge S, Roberts S, Ison G, Lin N, Gore L
. Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement. J Clin Oncol. 2017; 35(33):3737-3744.
PMC: 5692724.
DOI: 10.1200/JCO.2017.73.7916.
View
2.
Gerber D, Singh H, Larkins E, Ferris A, Forde P, Selig W
. A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria. JAMA Oncol. 2022; 8(9):1333-1339.
PMC: 9934063.
DOI: 10.1001/jamaoncol.2022.1664.
View
3.
Hantel A, Luskin M, Khan I, Warner E, Patel A, Walsh T
. Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia. Haematologica. 2023; 109(4):1046-1052.
PMC: 10985457.
DOI: 10.3324/haematol.2023.283723.
View